-
Stem cell therapy fails to improve symptoms of peripheral artery disease
pharmafile
November 17, 2017
A new study has revealed that a promising stem cell therapy failed to improve ability to walk in patients with peripheral artery disease (PAD), a condition that causes pain or weakness in the legs due to atherosclerotic blockages in the legs.
-
Stem cell therapy shows promise for macular degeneration
europeanpharmaceuticalreview
November 16, 2017
Studies show cell-based treatment is safe in patients with dry macular degeneration, with one showing improved vision…
-
Repairing broken hearts with injectable patches
fiercebiotech
August 15, 2017
Patches small enough to be injected with a needle are showing promise for repairing damaged hearts.
-
Sartorius and Science Magazine to Award Prize for Regenerative Medicine and Cell Therapy
biospectrumasia
June 28, 2017
Sartorius together with the renowned Science magazine will award a Sartorius & Science Prize for Regenerative Medicine & Cell Therapy.
-
Orchard Inks Mfg. Agreement with PCT Cell Therapy
contractpharma
June 06, 2017
Orchard Therapeutics has entered a clinical manufacturing services agreement with PCT Cell Therapy Services, a provider of contract services for the development and manufacture of cell-based therapeutic and regenerative medicine products.
-
Orchard Therapeutics signs manufacturing services agreement with PCT Cell Therapy Services
cphi-online
June 02, 2017
Under the terms of this new agreement, PCT will provide GMP-compliant manufacturing services for Orchard’s lead product, OTL-101, an autologous ex-vivo gene therapy for the treatment of ADA-SCID.
-
Orchard Therapeutics Ltd. announces manufacturing services agreement with PCT Cell Therapy Services
biospectrumasia
May 31, 2017
Under the terms of this new agreement, PCT will provide GMP-compliant manufacturing services for Orchard’s lead product, OTL-101
-
UK’s Innovation Agency Backs Plasticell
contractpharma
April 14, 2017
Cell therapy producer will make red blood cell substitute from pluripotent stem cells
-
Towards a safe and scalable cell therapy for type 1 diabetes by simplifying beta cell differentiatio
worldpharmanews
April 10, 2017
More than 36 million people globally are affected by type 1 diabetes (T1D), a lifelong disorder where insulin producing cells are attacked and destroyed by the immune system resulting in deficient insulin production that requires daily blood glucose monit
-
Hitachi Chemical Acquires Remaining Stake in PCT for $75M
contractpharma
March 20, 2017
Redefines Caladrius as a cell therapeutics-only development company with multiple technology platforms